In Brief This Week: Vermillion; NCGR, Isilon; Gelcompany, Max Planck Institute for Biochemistry; Linguamatics | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Vermillion this week said that it will work with reimbursement services firm Premiere Source Diagnostics for the OVA1 triage ovarian cancer test.

In addition, the firm said that the US Bankruptcy Court in Delaware has approved the final fee application in its Chapter 11 reorganization case. The total professional fees and expenses were about $3.8 million, of which $2.7 million remained unpaid as of March 31.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.